期刊文献+

高危型人乳头状瘤病毒在子宫颈癌组织和外周血表达的意义

Expression of high risk type human papillomavirus in the tissues and peripheral blood of cervical carcinomas
下载PDF
导出
摘要 目的:分别检测子宫颈癌组织和外周血标本中人乳头状瘤病毒(HPV)(16型,18型),探讨HPV感染与子宫颈癌的关联性以及在肿瘤微转移中的表达.方法:采用荧光定量PCR(FQ-PCR)和逆转录PCR(RT-PCR)技术检测24份子宫颈癌组织及其治疗前后48份外周血标本,慢性子宫颈炎组织及其外周血标本各20份.结果:24份子宫颈癌组织(Ⅰ~Ⅱb期)中HPV DNA 16型阳性率为66.7%,HPV DNA 18型阳性率为29.2%,两型均阳性的阳性率为8.3%;48份外周血标本HPV mRNA 16型阳性率为2.1%;20份慢性子宫颈炎组织HPV DNA 16型阳性率为15.0%,HPV18型为阴性,其外周血均为阴性.子宫颈癌HPV DNA 16型组与慢性子宫颈炎HPV DNA 16型组比较差异有统计学意义(P<0.005~P<0.05).结论:高危型HPV感染与子宫颈癌发生高度相关.外周血HPV检出率低,临床价值有待进一步研究. Objective:To detect expression of human papillomavirus(HPV) type 16 and 18 in carcinoma tissues and peripheral blood of patients with cervical carcinomas,and to explore the relationship between HPV infection and cervical carcinomas,as well as its expression in tumour micrometastase.Methods:Real-time fluorescence quantitative PCR(FQ-PCR) and reverse transcription polymerase chain reaction(RT-PCR) were used to detect HPV in 24 cases of tissues and 48 samples of peripheral blood of cervical carcinomas,and 20 cases of tissues and 20 smples of peripheral blood of chronic cervicitis.Results:In the 24 tissues of cervical carcinomas(Ⅰ-Ⅱb),the positive rate of HPV DNA type 16 was 66.7%;the positive rate of HPV DNA type 18 was 29.2%;the positive rate of both positive HPV DNA 16 and HPV DNA 18 was 8.0%.In the 48 samples of peripheral blood cervical carcinomas,the positive rate of HPV mRNA type 16 was 2.1%.In the 20 chronic cervicitis tissues,the positive rate of HPV DNA type 16 was 15.0% and HPV DNA type 18 was negative.Both HPV type 16 and 18 of peripheral blood were negative.The difference was markedly significant between cervical carcinomas and chronic cervicitis(P<0.005-P<0.05).Conclusions:The quantitation of HPV is highly associated with cervical carcinomas.Detection of HPV mRNA in the peripheral blood of cervical carcinomas is low,and its clinical significance needs further evaluation.
出处 《蚌埠医学院学报》 CAS 2007年第6期647-649,共3页 Journal of Bengbu Medical College
基金 安徽省教育厅自然科学研究资助项目(2005kj048zd)
关键词 子宫颈肿瘤 人乳头状瘤病毒 荧光定量聚合酶链反应 微转移 cervix neoplasms human papillomaviruses fluorescence quantitative polymerase chain reaction micrometastasis.
  • 相关文献

参考文献9

  • 1[1]zur Hausen H,Meinhof W,Scheiber W,et al.Attempts to detect virus-secific DNA in human tumors.I.Nucleic acid hybridizations with complementary RNA of human wart virus[J].Int J Cancer,1974,13(5):650-656.
  • 2[2]Schiffman MH,Brinton LA.The epidemiology of cervical carcinogenesis[J].Cancer,1995,76(10 Suppl):1 888-1 901.
  • 3[3]Trottier H,Franco EL.The epidemiology of genital human papillomavirus infection[J].Vaccine,2006,24(Suppl 1):S1-S15.
  • 4徐波,胡丽娜,顾美礼.人乳头状瘤病毒E6、E7原癌蛋白致癌的机制[J].国外医学(妇产科学分册),2001,28(4):198-200. 被引量:18
  • 5[6]Zehbe I,Wilander E.Human papillomavirus infection and invasive cervical neoplasia:a study of prevalence and morphology[J].J Pathol,1997,181(3):270-275.
  • 6[7]Mitchell MF,Tortolero-Luna G,Wright T,et al.Cervical human papillomavirus infection and intraepithelial neoplasia:A review[J].J Natl Cancer Inst Monogr,1996,21(1):17-25.
  • 7马彩玲,李轶杰,张富春,王国荃,郑玉建,开丽曼,热西旦,韩英,帕提古丽.应用荧光定量聚合酶链方法检测宫颈组织中人乳头瘤病毒16E6基因[J].中华医学杂志,2004,84(6):469-473. 被引量:13
  • 8[9]Liu VW,Tsang P,Yip A,et al.Low incidence of HPV DNA in sera of pretreatment cervical cancer patients[J].Gynecol Oncol,2001,82(2):269-272.
  • 9程玺,蔡树模,李子庭,孙孟红,张泰明,吴小华.宫颈癌患者外周血中CK19 mRNA和HPV16 mRNA基因的检测及其意义[J].中国癌症杂志,2004,14(4):313-316. 被引量:5

二级参考文献29

  • 1Tseng CJ, Pao CC, Lin JD, et al. Detection of human papillomavirus types 16 and 18 mRNA in peripheral blood of advanced cervical cancer patients and its association with prognosis[J]. J Clin Oncol, 1999, 17(5):1391-1396.
  • 2Stenman J, Lintula S, Hotakainen K, et al. Detection of squamous-cell carcinoma antigen-expressing tumour cells in blood by reverse rranscriptase-polymerase chain reaction in cancer of the uterine cervix[J]. Int J Cancer, 1997,74(1):75-80.
  • 3Lin JC, Chen KY, Wang WY, et al. Evaluation of cytokeratin-19 mRNA as a tumor maker in the peripheral blood of nasopharyngeal carcinoma patients receiving concurrent chemorediotherapy[J]. Int J Cancer, 2002,97(4):548-553.
  • 4Ruud P, Fodstad O, Hovig E. Identification of a novel cytokeratin 19 psedogene that may interfere with reverse transcriptase-polymerase chain reaction assays used to detect micrometastatic tumor cells[J]. Int J Cancer, 1999, 80(1):119-125.
  • 5Wang-Johanning F, Lu DW, Wang Y, et al. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis[J]. Cancer, 2002,94(8):2199-2210.
  • 6Yuan CC, Wang PH, Ng HT, et al. Detecting cytokeratin 19 mRNA in the peripheral blood cells of cervical cancer patients and its clinical-pathological correlation[J]. Gynecol Oncol, 2002,85(1):148-153.
  • 7zur Hausen H. Human papillomaviruses in the pathogenesis of anogenital cancer[J]. Virology,1991,184(1):9-13.
  • 8Liu VW, Tsang P, Yip A, et al. Low incidence of HPV DNA in sera of pretreatment cervical cancer patients[J]. Gynecol Oncol, 2001, 82(2):269-272.
  • 9Pao CC, Hor JJ, Yang FP, et al. Detection of human papillomavirus mRNA and cervical cancer cells in peripheral blood of cervical cancer patients with metastasis[J]. J Clin Oncol,1997,15(3):1008-1012.
  • 10Duk JM, Groenier KH, de Bruijn HW, et al. Pretreatment serum squamous cell carcinoma antigen: a newly identified prognostic factor in early-stage cervical carcinoma[J]. J Clin Oncol,1996, 14(1):111-118.

共引文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部